Clinical Trials Browser

OTHER × Papillomavirus Infections × Papillomavirus Vaccines × Clear all

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

Phase 4 Active not recruiting

92 enrolled

Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01824537 2025-03-19

TRAP-HPV

Phase 4 Completed

372 enrolled 12 charts

Papillomavirus Infections

NCT06700941 2024-11-22

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Completed

8,000,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT06686043 2024-11-13

HPV-VIM

Phase 2 Recruiting

85 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

NCT05173324 2022-08-03

H2VICTORY

Phase 3 Not yet recruiting

8,000 enrolled

HIV Infections, Papillomavirus Infections

NCT04171505 2019-11-21

VENUS

Unknown

508 enrolled

Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Clinical Trials

Intradermal, Fractional Dose of HPV Vaccines:

Immunogenicity of Fractional Dose of the HPV Vaccines

AGO-Gard

TRAP-HPV

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

HPV-VIM

H2VICTORY

VENUS